Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 32 |
| List of Tables | 28 | 5 |
| List of Figures | 33 | 1 |
| Introduction | 34 | 1 |
| Global Markets Direct Report Coverage | 34 | 1 |
| Neuropathic Pain Overview | 35 | 1 |
| Therapeutics Development | 36 | 2 |
| Pipeline Products for Neuropathic Pain Overview | 36 | 1 |
| Pipeline Products for Neuropathic Pain Comparative Analysis | 37 | 1 |
| Neuropathic Pain Therapeutics under Development by Companies | 38 | 12 |
| Neuropathic Pain Therapeutics under Investigation by Universities/Institutes | 50 | 2 |
| Neuropathic Pain Pipeline Products Glance | 52 | 4 |
| Late Stage Products | 52 | 1 |
| Clinical Stage Products | 53 | 1 |
| Early Stage Products | 54 | 1 |
| Unknown Stage Products | 55 | 1 |
| Neuropathic Pain Products under Development by Companies | 56 | 14 |
| Neuropathic Pain Products under Investigation by Universities/Institutes | 70 | 2 |
| Neuropathic Pain Companies Involved in Therapeutics Development | 72 | 121 |
| 2-BBB Medicines BV | 72 | 1 |
| AbbVie Inc. | 73 | 1 |
| Achelios Therapeutics, Inc. | 74 | 1 |
| Adynxx, Inc. | 75 | 1 |
| Aestus Therapeutics, Inc. | 76 | 1 |
| Affectis Pharmaceuticals AG | 77 | 1 |
| Amura Holdings Limited | 78 | 1 |
| AnaBios Corporation | 79 | 1 |
| Anavex Life Sciences Corp. | 80 | 1 |
| AngioChem Inc. | 81 | 1 |
| APT Therapeutics, Inc. | 82 | 1 |
| Arena Pharmaceuticals, Inc. | 83 | 1 |
| Asahi Kasei Pharma Corp. | 84 | 1 |
| Astellas Pharma Inc. | 85 | 1 |
| AstraZeneca Plc | 86 | 1 |
| BCI Pharma | 87 | 1 |
| BCN Peptides, S.A. | 88 | 1 |
| Benitec Biopharma Limited | 89 | 1 |
| BioDelivery Sciences International, Inc. | 90 | 1 |
| Biogen, Inc. | 91 | 1 |
| BioLineRx, Ltd. | 92 | 1 |
| Biomar Microbial Technologies | 93 | 1 |
| Bionomics Limited | 94 | 1 |
| Bristol-Myers Squibb Company | 95 | 1 |
| Can-Fite BioPharma Ltd. | 96 | 1 |
| Cara Therapeutics, Inc. | 97 | 1 |
| Catalyst Biosciences, Inc. | 98 | 1 |
| Cavion LLC | 99 | 1 |
| Centrexion Corporation | 100 | 1 |
| Cerecor Inc. | 101 | 1 |
| Chromocell Corporation | 102 | 1 |
| Circuit Therapeutics, Inc. | 103 | 1 |
| CLL Pharma | 104 | 1 |
| Colby Pharmaceutical Company | 105 | 1 |
| ContraVir Pharmaceuticals, Inc. | 106 | 1 |
| Creabilis SA | 107 | 1 |
| Crinetics Pharmaceuticals, Inc. | 108 | 1 |
| Cytogel Pharma, LLC | 109 | 1 |
| Daewoong Pharmaceutical Co., Ltd. | 110 | 1 |
| Daiichi Sankyo Company, Limited | 111 | 1 |
| DermaXon, LLC | 112 | 1 |
| Develco Pharma Schweiz AG | 113 | 1 |
| Dompe Farmaceutici S.p.A. | 114 | 1 |
| Eisai Co., Ltd. | 115 | 1 |
| Eli Lilly and Company | 116 | 1 |
| Endece, LLC | 117 | 1 |
| F. Hoffmann-La Roche Ltd. | 118 | 1 |
| Genecode AS | 119 | 1 |
| Glenmark Pharmaceuticals Ltd. | 120 | 1 |
| Glialogix, Inc. | 121 | 1 |
| Grunenthal GmbH | 122 | 1 |
| GW Pharmaceuticals Plc | 123 | 1 |
| Hydra Biosciences, Inc. | 124 | 1 |
| Immune Pharmaceuticals Inc. | 125 | 1 |
| Integral Molecular, Inc. | 126 | 1 |
| IntelGenx Corp. | 127 | 1 |
| Intellipharmaceutics International Inc. | 128 | 1 |
| Jeil Pharmaceutical Co., Ltd. | 129 | 1 |
| Jiangsu Nhwa Pharmaceutical Corporation Ltd. | 130 | 1 |
| Johnson &Johnson | 131 | 1 |
| Kareus Therapeutics, SA | 132 | 1 |
| Kineta, Inc. | 133 | 1 |
| Knopp Biosciences LLC | 134 | 1 |
| Laboratorios Del Dr. Esteve S.A. | 135 | 1 |
| LEO Pharma A/S | 136 | 1 |
| Lexicon Pharmaceuticals, Inc. | 137 | 1 |
| Lipopharma Therapeutics SL | 138 | 1 |
| Lohocla Research Corporation | 139 | 1 |
| Lpath, Inc. | 140 | 1 |
| Mapi Pharma Ltd. | 141 | 1 |
| Medestea Research &Production S.p.A. | 142 | 1 |
| Medisyn Technologies, Inc. | 143 | 1 |
| Medy-Tox Inc. | 144 | 1 |
| Merck &Co., Inc. | 145 | 1 |
| Nanomerics Ltd | 146 | 1 |
| Nektar Therapeutics | 147 | 1 |
| Neurim Pharmaceuticals Ltd | 148 | 1 |
| Neurocentrx Pharma Ltd. | 149 | 1 |
| Neurodyn Inc. | 150 | 1 |
| NeurOp, Inc | 151 | 1 |
| Newron Pharmaceuticals S.p.A. | 152 | 1 |
| Nippon Chemiphar Co., Ltd. | 153 | 1 |
| NoNO, Inc. | 154 | 1 |
| Novaremed | 155 | 1 |
| Novartis AG | 156 | 1 |
| NsGene A/S | 157 | 1 |
| Orion Oyj | 158 | 1 |
| PeriphaGen, Inc. | 159 | 1 |
| Pfizer Inc. | 160 | 1 |
| Pharmaleads SA | 161 | 1 |
| PharmEste | 162 | 1 |
| Phosphagenics Limited | 163 | 1 |
| Prismic Pharmaceuticals, Inc. | 164 | 1 |
| RaQualia Pharma Inc. | 165 | 1 |
| Re-Pharm Limited | 166 | 1 |
| Recro Pharma, Inc. | 167 | 1 |
| Relmada Therapeutics, Inc. | 168 | 1 |
| Revance Therapeutics, Inc. | 169 | 1 |
| Saniona AB | 170 | 1 |
| Scilex Pharmaceuticals, Inc. | 171 | 1 |
| Shionogi &Co., Ltd. | 172 | 1 |
| Sigma-Tau S.p.A. | 173 | 1 |
| SK Biopharmaceuticals Co., Ltd. | 174 | 1 |
| Sphaera Pharma Pvt. Ltd. | 175 | 1 |
| Spherium Biomed S.L. | 176 | 1 |
| Sunovion Pharmaceuticals Inc. | 177 | 1 |
| Syntrix Biosystems, Inc. | 178 | 1 |
| Takeda Pharmaceutical Company Limited | 179 | 1 |
| Teva Pharmaceutical Industries Ltd. | 180 | 1 |
| Theranexus SAS | 181 | 1 |
| Theravasc, Inc. | 182 | 1 |
| Toray Industries, Inc. | 183 | 1 |
| Torrent Pharmaceuticals Limited | 184 | 1 |
| Trevena, Inc. | 185 | 1 |
| Trigemina, Inc. | 186 | 1 |
| Vichem Chemie Research Ltd. | 187 | 1 |
| Virobay Inc. | 188 | 1 |
| VistaGen Therapeutics , Inc. | 189 | 1 |
| Yuhan Corporation | 190 | 1 |
| Yungjin Pharm. Co., Ltd. | 191 | 1 |
| Zynerba Pharmaceuticals, Inc. | 192 | 1 |
| Neuropathic Pain Therapeutics Assessment | 193 | 36 |
| Assessment by Monotherapy Products | 193 | 1 |
| Assessment by Combination Products | 194 | 1 |
| Assessment by Target | 195 | 13 |
| Assessment by Mechanism of Action | 208 | 17 |
| Assessment by Route of Administration | 225 | 2 |
| Assessment by Molecule Type | 227 | 2 |
| Drug Profiles | 229 | 302 |
| (amitriptyline + ketamine hydrochloride) Drug Profile | 229 | 4 |
| (clonidine hydrochloride + naltrexone hydrochloride) Drug Profile | 233 | 1 |
| (diclofenac sodium + triclocarban) Drug Profile | 234 | 1 |
| 2-B3201 Drug Profile | 235 | 2 |
| A-1262543 Drug Profile | 237 | 1 |
| A-1264087 Drug Profile | 238 | 1 |
| AFC-5128 Drug Profile | 239 | 1 |
| AK-106 Drug Profile | 240 | 1 |
| AM-3840 Drug Profile | 241 | 1 |
| AN-363 Drug Profile | 242 | 2 |
| AN-721 Drug Profile | 244 | 1 |
| ANAVEX-1037 Drug Profile | 245 | 1 |
| ANAVEX-1066 Drug Profile | 246 | 1 |
| ANAVEX-1067 Drug Profile | 247 | 1 |
| ANAVEX-1079 Drug Profile | 248 | 1 |
| ANAVEX-1519 Drug Profile | 249 | 1 |
| ANG-2002 Drug Profile | 250 | 1 |
| AP-325 Drug Profile | 251 | 1 |
| AP-61 Drug Profile | 252 | 1 |
| APD-371 Drug Profile | 253 | 1 |
| APT-102 Drug Profile | 254 | 2 |
| AQU-010 Drug Profile | 256 | 1 |
| AQU-118 Drug Profile | 257 | 1 |
| AS-1069562 Drug Profile | 258 | 1 |
| ATX-08001 Drug Profile | 259 | 2 |
| AV-101 Drug Profile | 261 | 3 |
| AXPN-03 Drug Profile | 264 | 1 |
| AYX-3 Drug Profile | 265 | 1 |
| BA-10 Drug Profile | 266 | 1 |
| BBI-11008 Drug Profile | 267 | 1 |
| BL-1110 Drug Profile | 268 | 2 |
| bupivacaine hydrochloride Drug Profile | 270 | 2 |
| C-746 Drug Profile | 272 | 1 |
| capsaicin Drug Profile | 273 | 1 |
| CC-8464 Drug Profile | 274 | 2 |
| cebranopadol Drug Profile | 276 | 3 |
| Cell Therapy for Central Nervous System Disorders Drug Profile | 279 | 1 |
| cetuximab Drug Profile | 280 | 6 |
| clonidine hydrochloride Drug Profile | 286 | 3 |
| CLP-257 Drug Profile | 289 | 1 |
| CMX-020 Drug Profile | 290 | 1 |
| CNTX-6016 Drug Profile | 291 | 1 |
| CNV-2197944 Drug Profile | 292 | 2 |
| CPC-123 Drug Profile | 294 | 1 |
| CR-4056 Drug Profile | 295 | 1 |
| CR-701 Drug Profile | 296 | 1 |
| CRB-0089 Drug Profile | 297 | 1 |
| crotalphine Drug Profile | 298 | 1 |
| CSTI-200 Drug Profile | 299 | 1 |
| CT-340 Drug Profile | 300 | 1 |
| Cyt-1010 Drug Profile | 301 | 2 |
| daxibotulinumtoxin A Drug Profile | 303 | 2 |
| DD-04107 Drug Profile | 305 | 1 |
| DDD-028 Drug Profile | 306 | 1 |
| DF-2593A Drug Profile | 307 | 1 |
| dronabinol Drug Profile | 308 | 1 |
| Drug for Cancer Neuropathic Pain Drug Profile | 309 | 1 |
| Drug to Antagonize Interleukin-1 Receptor for Neuropathic Pain Drug Profile | 310 | 1 |
| Drugs to Inhibit p38 MAP Kinase for Neuropathic Pain Drug Profile | 311 | 1 |
| Drugs to Inhibit SRC-ND2 Interaction for Neuropathic Pain and Inflammatory Pain Drug Profile | 312 | 1 |
| DSP-2230 Drug Profile | 313 | 1 |
| duloxetine hydrochloride DR Drug Profile | 314 | 2 |
| DWJ-208 Drug Profile | 316 | 1 |
| DWP-05195 Drug Profile | 317 | 1 |
| DX-0332 Drug Profile | 318 | 1 |
| E-2072 Drug Profile | 319 | 1 |
| EC-5026 Drug Profile | 320 | 1 |
| ECL-1 Drug Profile | 321 | 1 |
| EMA-401 Drug Profile | 322 | 3 |
| etifoxine Drug Profile | 325 | 1 |
| fadolmidine hydrochloride Drug Profile | 326 | 1 |
| filgrastim Drug Profile | 327 | 1 |
| Flexicaine Peel Drug Profile | 328 | 1 |
| funapide Drug Profile | 329 | 2 |
| FV-100 Drug Profile | 331 | 4 |
| GERP-001 Drug Profile | 335 | 1 |
| GLX-1112 Drug Profile | 336 | 1 |
| GRC-17536 Drug Profile | 337 | 2 |
| GRTTA-2210 Drug Profile | 339 | 1 |
| HPI-201 Drug Profile | 340 | 1 |
| HX-100 Drug Profile | 341 | 2 |
| hydralazine hydrochloride Drug Profile | 343 | 1 |
| IMB-1007 Drug Profile | 344 | 1 |
| IPI-940 Drug Profile | 345 | 1 |
| JNJ-40413269 Drug Profile | 346 | 1 |
| JNJ-47965567 Drug Profile | 347 | 1 |
| ketamine hydrochloride Drug Profile | 348 | 2 |
| ketamine hydrochloride PR Drug Profile | 350 | 1 |
| ketoprofen Drug Profile | 351 | 1 |
| Kindolor Drug Profile | 352 | 1 |
| KM-113 Drug Profile | 353 | 1 |
| KM-314 Drug Profile | 354 | 1 |
| L-779976 Drug Profile | 355 | 1 |
| LASSBio-873 Drug Profile | 356 | 1 |
| levorphanol tartrate ER Drug Profile | 357 | 2 |
| lidocaine hydrochloride Drug Profile | 359 | 1 |
| lidocaine hydrochloride patch Drug Profile | 360 | 1 |
| LPA-181 Drug Profile | 361 | 1 |
| Lpathomab Drug Profile | 362 | 3 |
| LX-9211 Drug Profile | 365 | 1 |
| MDA-7 Drug Profile | 366 | 1 |
| MED-1101 Drug Profile | 367 | 1 |